Human tumor samples and in vivo patient-derived xenograft and syngeneic murine models were administered Wnt/β-catenin modulating agents DKN-01 and CGX-1321 individually or in sequence
[Gynecological Oncology]
Sorry, but the selected Zotpress account can't be found.